📰 Marks Levine News
Marks Levine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Marks Levine. Real-time updates on events, politics, business and more.
May 18, 2024
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 8,960,000 shares, a growth of 5.3% from the April 15th total of 8,510,000 shares. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is […]
February 24, 2024
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Mark S. Levine sold 2,134 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $36.15, for a total transaction of $77,144.10. Following the sale, the insider now owns 301,968 shares in the company, valued […]
February 16, 2024
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities research analysts at HC Wainwright raised their FY2028 earnings per share estimates for shares of Immunovant in a research note issued to investors on Tuesday, February 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of $2.16 for the year, […]
November 22, 2023
Shares of Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) have received an average rating of “Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. Thirteen equities research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the […]
October 28, 2023
Immunovant (NASDAQ:IMVT – Free Report) had its target price hoisted by HC Wainwright from $29.00 to $47.00 in a report published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Immunovant’s Q3 2024 earnings at ($0.55) EPS, Q4 2024 earnings at ($0.55) EPS, FY2024 […]
October 13, 2023
Several brokerages have updated their recommendations and price targets on shares of Immunovant (NASDAQ: IMVT) in the last few weeks: 10/13/2023 – Immunovant was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $55.00 price target on the stock, up previously from $18.00. 10/9/2023 – […]
July 28, 2023
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Mark S. Levine sold 3,917 shares of the company’s stock in a transaction on Wednesday, July 26th. The stock was sold at an average price of $21.63, for a total transaction of $84,724.71. Following the completion of the transaction, the insider now owns 326,774 shares of the […]
March 24, 2023
Immunovant, Inc. (NASDAQ:IMVT – Get Rating)’s share price was down 3.1% during mid-day trading on Wednesday . The company traded as low as $15.70 and last traded at $15.70. Approximately 51,566 shares traded hands during trading, a decline of 95% from the average daily volume of 1,023,167 shares. The stock had previously closed at $16.21. […]